Lupin's 4.5% rise pushes Nifty Pharma index up by 1.5%

Govt proposes to bring fixed-dose combinations under price control
Pharma stocks were in focus in today’s trade with Lupin surging as much as 4.7%, becoming the biggest gainer on both the frontline indices.


The pharma major helped Nifty Pharma gain over 1.5% in today’s trade, making it the top performing index among other sectoral indices. BSE Healthcare index also gained 1.4%.


In the month of June, Nifty Phrma rallied over 6%, a change of pace from the 11% fall in May 2017. The index has been up 1.6% in July so far but is down 6.5% in 2027 till date.


Followed by Lupin, shares of Divis Lab was trading higher by 2%, Dr Reddy’s advanced 2%, Cadila Healthcare rose 0.5% and Cipla was up by 1.4%


At 11:04 am Lupin was currently trading at Rs 1126, up by Rs 45 or 4.15% from its previous closing of Rs 1081.25 on the BSE.


The scrip opened at Rs 1089.7 and has touched a high and low of Rs 1,132 and Rs 1,085 respectively. So far 14,62,349 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 48,842.65 crore.

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel